Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Long-term safety of ivermectin 1% cream vs azelaic...
Journal article

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

Abstract

Papulopustular rosacea (PPR) is characterized by facial erythema and inflammatory lesions believed to be primarily caused by dysregulation of the innate immune system. More recent evidence also suggests that Demodex folliculorum mites may contribute to the etiology of PPR. Ivermectin (IVM) 1% cream is a novel topical treatment developed to treat PPR. Two phase 3 trials have demonstrated that IVM 1% cream was significantly better than vehicle at …

Authors

Stein Gold L; Kircik L; Fowler J; Jackson JM; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C

Journal

Journal of Drugs in Dermatology, Vol. 13, No. 11, pp. 1380–1386

Publication Date

November 2014

ISSN

1545-9616